// App-Quantinova.ai

e17612 : Survival outcomes of patients (pts) who received filgrastim (fil) or pegfilgrastim (peg) in clinical trials.

Researchers

Presenter

  • Gary H. Lyman

Principal Investigators

  • Maureen Reiner

  • Phuong Khanh H. Morrow

  • Jeffrey Crawford

Medical Centers

  • Duke University Medical Center, Durham, NC

  • Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WAGenentech Inc., South San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pegfilgrastim

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Amgen

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved